Magazine
Latest Issue

Lab report

Britain may stand shoulder to shoulder with the US on geopolitics, but not on stem-cell research, where Blair is exploiting the US's self-imposed weakness

By Philip Ball   September 2006

More ethics of stem-cell research President Bush’s veto in July on a bill to revise US stem-cell funding boosts the bioscience business opportunities for the British government. Tony Blair has been in California seeking to strengthen links with leading biotech companies there. And co-operation with the US west coast is due to be secured in a joint conference on stem-cell research, hosted in Britain in November.

In the ethical debate over stem cells, taken from surplus embryos in fertility treatment and used to research remedies for diseases such as Alzheimer’s and cancer, Britain and the US apparently do not stand…

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to letters@prospect-magazine.co.uk

More From Prospect